Register for our newsletter
Menu
The Parliament Magazine

Subscribe to The Parliament

Subscribe now
Subscribe now
  • EU Institutions
  • Member States
  • Foreign & Security Policy
  • Economics
  • Technology
  • Energy & Environment
  • More
    • About
    • Print magazine
    • Newsletter
    • Events
    • Training
    • Commercial Opportunities
    • Become a PM+ Member
    • Members Directory
    • Guide to the Cyprus Presidency of the Council of the EU
Search
  • News analysis
  • Feature
  • Q+A
  • Opinion
  • Newsletter
    More

    Follow us:

    The Parliament
    • EU Institutions
    • Member States
    • Foreign & Security Policy
    • Economics
    • Technology
    • Energy & Environment
    • More
      • About
      • Print magazine
      • Newsletter
      • Events
      • Training
      • Commercial Opportunities
      • Become a PM+ Member
      • Members Directory
      • Guide to the Cyprus Presidency of the Council of the EU

    Author Profile

    Full list of news written by this author
    Claire Skentelbery

    Claire Skentelbery

    Director General for EuropaBio

    Empowering innovation: The future of rare disease therapies in Europe Partner Content
    23 Feb 24 Technology
    Empowering innovation: The future of rare disease therapies in Europe
    With biotech companies playing a pivotal role in finding therapies for people living with rare diseases, Europe has the potential to lead the charge in revolutionising new treatments
    A monthly magazine packed with timely features, news analyses and opinion articles on EU policy.
    Subscribe

    Subscribe to The Parliament

    Subscribe now

    Follow us

    Registered in England & Wales under No. 07291783

    © Political Holdings Limited

    Services
    • Media
    • Events
    • Training
    Media & Publishing
    • PoliticsHome
    • Holyrood
    • Civil Service World
    • The House Magazine
    • PublicTechnology
    • Training Journal
    • Subscribe to Total Politics media titles
    About Us
    • Total Politics Group
    • Privacy Policy
    • Terms & Conditions